Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments

Rheumatoid arthritis (RA) is a systemic immune disease characterized by synovial inflammation. Patients with RA commonly experience significant damage to their hand and foot joints, which can lead to joint deformities and even disability. Traditional treatments have several clinical drawbacks, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Xiao-Kai, Xu, Xiao-Ling, Chen, Bang-Yao, Su, Jin, Du, Yong-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039584/
https://www.ncbi.nlm.nih.gov/pubmed/36964609
http://dx.doi.org/10.1186/s12951-023-01857-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039584/
https://www.ncbi.nlm.nih.gov/pubmed/36964609
http://dx.doi.org/10.1186/s12951-023-01857-8

Ejemplares similares